(Q39326977)

11 September 2017

title

Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes (English)

1 reference

11 September 2017

0 references

Wenbing Dai

1

0 references

You Wan

object named as

You Wan

7

0 references

author name string

Wu Jin

2

1 reference

11 September 2017

Junlin Zhang

3

1 reference

11 September 2017

Xueqing Wang

4

1 reference

11 September 2017

Jiancheng Wang

5

1 reference

11 September 2017

Xuan Zhang

6

1 reference

11 September 2017

Qiang Zhang

8

1 reference

11 September 2017

publication date

22 June 2012

1 reference

11 September 2017

published in

Pharmaceutical Research

1 reference

11 September 2017

volume

29

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

2902-2911

1 reference

Nanoparticle and targeted systems for cancer therapy

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Synergistic effect of enhancers for transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Vascular-targeting therapies for treatment of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Are tumours angiogenesis-dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Ligand-targeted liposomes for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Distribution of somatostatin receptors in normal and tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Somatostatin, cortistatin and their receptors in tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Design, synthesis, and biological evaluation of somatostatin-based radiopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Sulforhodamine B colorimetric assay for cytotoxicity screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Control of Multivalent Interactions by Binding Epitope Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0797-2

Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer

21 January 2018

1 reference

12 December 2020

Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice

1 reference

12 December 2020

Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient

1 reference

12 December 2020

Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor

1 reference

12 December 2020

Combretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary thyroid carcinoma

1 reference

12 December 2020

10.1007/S11095-012-0797-2

Identifiers

DOI

1 reference

11 September 2017

1 reference